lukas

Newly discovered genetic defect disrupts blood formation and immune system

Newly discovered genetic defect disrupts blood formation and immune system (Vienna, 21.06.2023) In the quest to find the origin of the puzzling symptoms in four children, researchers from St. Anna Children’s Cancer Research Institute, the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences (ÖAW), and the Medical University of Vienna have discovered […]

Newly discovered genetic defect disrupts blood formation and immune system Read More »

The first-ever ITCC Scientific Days concluded with big success! 

The first-ever ITCC Scientific Days concluded with big success!  The Innovative Therapies for Children with Cancer (ITCC) conference brought together leading international experts and researchers in pediatric oncology to discuss the latest advancements, challenges, and opportunities in understanding and treating pediatric cancers.  Exciting breakthroughs were discussed, including a novel treatment approach for high-grade gliomas that

The first-ever ITCC Scientific Days concluded with big success!  Read More »

EuSARC 2023 in Vienna: Bringing together sarcoma researchers from across the world

EuSARC 2023 in Vienna: Bringing together sarcoma researchers from across the world (Vienna, 25.5.2023) St. Anna Children’s Cancer Research Institute is happy to have hosted this year’s EuSARC conference in Vienna covering multi-disciplinary topics from molecular mechanisms to novel therapies in sarcomas! Thanks to all the great speakers and attendees! “We are very excited to see

EuSARC 2023 in Vienna: Bringing together sarcoma researchers from across the world Read More »

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna (Vienna, May 23, 2023) On May 25th, the first two-day conference of the consortium for “Innovative Therapies for Children with Cancer in Europe” (ITCC) will start in Vienna. St. Anna Children’s Cancer Research Institute, St. Anna Children’s Hospital, and the Pediatric Neuro-Oncology

Innovative Therapies for Children with Cancer: ITCC Conference for the first time in Vienna Read More »

“Children are our future. It’s really important to take care of them.”

“Children are our future. It’s really important to take care of them.” (Vienna, 11.5.2023) Maria Happel in brief: Why she supports the St. Anna Children’s Cancer Research Institute, how she deals with criticism, and what acting in plays has to do with healing the soul. Under the motto of our 35th anniversary “Reaching for the stars”, we

“Children are our future. It’s really important to take care of them.” Read More »

„I think it’s our job as scientists to prepare research in a communicative way!” – Panel Discussion

That was the first Panel Discussion – “Reaching for the Stars – We & Science!” (Vienna, 25.04.2023) The new discussion series “Reaching for the Stars – We & Science!” in cooperation with the Wiener Zeitung started last Tuesday with an inspiring exchange between St. Anna CCRI Principal Investigator Caroline Hutter and Science Buster Martin Moder.

„I think it’s our job as scientists to prepare research in a communicative way!” – Panel Discussion Read More »

18.04.23 / Panel Discussion “Reaching for the Stars – We & Science” 

Panel Discussion: “Reaching for the Stars – We & Science”  in cooperation with the Wiener Zeitung. Making the impossible possible – and thus reaching for the stars. This is the claim that St. Anna Children’s Cancer Research Institute has successfully realized in its 35 years of existence. With the clear mission of enabling children with

18.04.23 / Panel Discussion “Reaching for the Stars – We & Science”  Read More »

Today is RARE DISEASE DAY: We are committed to rare disease research! 

Today is RARE DISEASE DAY: We are committed to rare disease research!  (Vienna, 28.02.2023) 300 million people worldwide suffer from rare diseases. Today is Rare Disease Day – a day to raise awareness for precisely these diseases. Together with the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, CeMM Research Center for Molecular Medicine of

Today is RARE DISEASE DAY: We are committed to rare disease research!  Read More »

Evolution 2.0: What makes cancer more malignant

Evolution 2.0: What makes cancer more malignant (Vienna, 23.09.2022) Congratulations! A paper has just been published in the top journal Nature Genetics, with the participation of Dr. Sabine Taschner-Mandl and Dr. Marie Bernkopf from St. Anna CCRI. The authors of this outstanding paper show that random inheritance patterns of cancer genes outside the chromosome, i.e. the scaffold

Evolution 2.0: What makes cancer more malignant Read More »